GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	558,879	487,432	329,173	224,319	281,714	244,012
Market Cap Growth	48.08%	48.08%	46.74%	-20.37%	15.45%	15.67%
Enterprise Value	533,997	466,472	313,334	211,499	270,099	237,483
Last Close Price	3295.00	2843.28	1889.18	1257.08	1489.75	1263.15
PE Ratio	60.25	52.55	55.80	36.73	16.62	68.13
PS Ratio	14.91	13.00	9.53	6.90	8.59	8.34
PB Ratio	28.64	24.98	18.52	12.88	10.58	16.51
P/TBV Ratio	28.84	25.15	18.77	13.14	10.72	17.01
P/FCF Ratio	44.11	38.48	59.76	50.96	36.30	45.72
P/OCF Ratio	43.33	37.79	56.56	46.33	34.75	42.22
EV/Sales Ratio	14.24	12.44	9.07	6.50	8.24	8.12
EV/EBITDA Ratio	45.60	40.47	35.58	26.83	36.36	41.42
EV/EBIT Ratio	47.92	41.86	37.35	28.26	38.65	45.71
EV/FCF Ratio	42.15	36.82	56.89	48.05	34.80	44.50
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.01	0.02	0.02	0.03	0.06
Debt / FCF Ratio	0.01	0.01	0.03	0.04	0.03	0.07
Asset Turnover	0.98	0.98	1.00	0.82	0.85	0.94
Inventory Turnover	2.81	2.81	2.75	2.62	2.55	2.49
Quick Ratio	1.50	1.50	1.45	1.50	1.83	1.02
Current Ratio	1.79	1.79	1.84	1.88	2.18	1.63
Return on Equity (ROE)	49.75%	49.75%	33.53%	27.59%	18.39%	17.42%
Return on Assets (ROA)	18.17%	18.17%	15.24%	11.75%	11.28%	10.39%
Return on Capital (ROIC)	37.07%	37.07%	29.52%	21.07%	20.82%	19.24%
Return on Capital Employed (ROCE)	50.60%	50.60%	41.30%	37.40%	23.80%	29.50%
Earnings Yield	1.66%	1.90%	1.79%	2.72%	6.02%	1.47%
FCF Yield	2.27%	2.60%	1.67%	1.96%	2.76%	2.19%
Dividend Yield	1.64%	1.48%	1.69%	2.55%	2.01%	2.38%
Payout Ratio	80.79%	80.79%	91.80%	249.80%	29.89%	189.04%
Total Shareholder Return	1.64%	1.48%	1.69%	2.55%	2.01%	2.38%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.